Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gastric Adenocarcinoma × sintilimab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 13 Stomach Neoplasms 9 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Pancreatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Turcot syndrome 1 Thyroid Neoplasms 1 Sarcoma 1 Salivary Gland Malignant Neoplasms 1 Rare Tumor 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasm Metastasis 1 NSCLC 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Meningeal Carcinomatosis 1 Lung Squamous Cell Carcinoma 1 Locally Recurrent Rectal Cancer 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2 Gastrectomy 2 trastuzumab deruxtecan 1 taxane 1 sintilimab 1 durvalumab 1 Taxes 1 Tadalafil 1 Platinum 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Immunotherapy, Adoptive 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Albumin-Bound Paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07263386 2025-12-04

ARTEMIS-GC3

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡